TSA vs RSA in Glenohumeral Osteoarthritis
SERVASA
Study Evaluating Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis: Protocol
1 other identifier
interventional
108
1 country
4
Brief Summary
This study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohumeral osteoarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2020
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2019
CompletedFirst Posted
Study publicly available on registry
January 14, 2020
CompletedStudy Start
First participant enrolled
March 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2032
March 25, 2025
March 1, 2025
9.8 years
December 17, 2019
March 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Western Ontario Osteoarthritis of the Shoulder Index (WOOS)
The Western Ontario Osteoarthritis of the Shoulder Index (WOOS) is a disease specific evaluation, proven to be an accurate and valid assessment of function after shoulder replacement. The WOOS is a patient-reported measure, 19-question survey. Each question is measured using a visual analog scale rated from 0-100, where higher scores mean better outcome.
24-Months and 5-Years Post-Operative
Secondary Outcomes (8)
Standard CT Scans
24-Months and 5-Years Post-Operative
American Shoulder and Elbow Surgeons Standardized Shoulder Assessment form (ASES)
24-Months and 5-Years Post-Operative
Pain Level
24-Months and 5-Years Post-Operative
Subjective Shoulder Value
24-Months and 5-Years Post-Operative
EuroQol EQ-5D-5L
24-Months and 5-Years Post-Operative
- +3 more secondary outcomes
Study Arms (2)
Total Shoulder Arthroplasty (anatomic)
ACTIVE COMPARATORTSA procedure involves replacing the worn-out ball and socket joint with prosthetic components.
Reverse Shoulder Arthroplasty
ACTIVE COMPARATORRSA procedure is similar to a TSA, however the orientation of the ball and socket joint is placed in the reverse position
Interventions
Replacement of the shoulder joint (ball and socket, or humeral head and glenoid) using prosthetic components.
Replacement of the shoulder joint like the TSA, however the orientation of the ball and socket is reversed.
Eligibility Criteria
You may qualify if:
- Patients who have failed standard non-surgical management of their idiopathic shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as:
- The use of drugs including analgesics and non-steroidal anti-inflammatory drugs
- Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)
- Activity modification
- Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss
- Patients may present with a glenoid deficiency and \</=15 degrees of retroversion
- years of age and older
You may not qualify if:
- Active joint or systemic infection
- Rotator cuff arthropathy
- Significant muscle paralysis
- Charcot's arthropathy
- Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)
- Unable to understand the consent form/process
- Pregnancy
- Psychiatric illness that precludes informed consent
- Unwilling to be followed for the duration of the study
- Retroversion cannot be surgically corrected to within 10 degrees of neutral
- History of previous shoulder surgery on affected side
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
University of Alberta
Edmonton, Alberta, T6G2G3, Canada
Pan Am Clinic Foundation
Winnipeg, Manitoba, R3M3E4, Canada
Kingston General Hospital (Site-Watkins 3)
Kingston, Ontario, K7L 2V7, Canada
The Ottawa Hospital
Ottawa, Ontario, K1H8L6, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Lapner, MD
The Ottawa Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2019
First Posted
January 14, 2020
Study Start
March 9, 2020
Primary Completion (Estimated)
January 1, 2030
Study Completion (Estimated)
December 31, 2032
Last Updated
March 25, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared with other researchers, who are not participating in the study.